Advancing cancer research. Transforming patient care.
Alliance clinical trials generate the evidence that advances new treatment, improves how cancer is detected and treated, and helps define the future of patient care.
99,988+
Participants Enrolled in Alliance Trials
1,490+
Alliance Member Institutions / Sites
39+
Alliance Trials Enrolling Participants
Practice Changing Alliance Trials
In the past 12 months, three Alliance clinical trials have led to FDA approvals, helping bring new treatment options to patients:
“Clinical trials are an essential part of making progress against cancer, often leading to FDA approvals, influencing national guidelines and creating new standards of care.”
What is the Alliance?
The Alliance for Clinical Trials in Oncology designs and conducts innovative cancer clinical trial across a network of nearly 1,500 academic and community cancer centers. This network gives patients across the country opportunities to participate in clinical research while helping clinicians and researchers evaluate new approaches to cancer prevention, treatment, and care.
NCI-Supported Trials
Turning important cancer questions into large-scale, national clinical trials.
Alliance Foundation Trials (AFT)
Expanding cancer approaches in clinical research through industry partnerships.
Academic + Community Network
Connecting research with patients and communities nationwide.
News from Alliance
Next Group Meeting: November 4-6, 2026
Join us in Chicago for the Spring and Fall Group meetings, where Alliance members come together to share research, advance clinical trials, and strengthen collaboration across the cancer research community.
Subscribe to our newsletter
Elect to receive regular trial updates from the Alliance for Clinical Trials in Oncology.